Glycoglycerolipid analogues inhibit PKC translocation to the plasma membrane and downstream signaling pathways in PMA-treated fibroblasts and human glioblastoma cells, U87MG

European Journal of Medicinal Chemistry

Volumn 46, Issue 5, 2011, Pages 1827-1834

  Colombo, Diego ^a   Tringali, Cristina ^a   Franchini, Laura ^a   Cirillo, Federica ^a   Venerando, Bruno ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Chemoprevention; Glioblastoma; Glycoglycerolipids; PKC

Indexed keywords

2 O BETA DEXTRO GALACTOSYLGLYCEROL; GLYCEROL DERIVATIVE; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CELL ADHESION; CELL MEMBRANE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME ACTIVATION; ENZYME INHIBITION; FIBROBLAST; GLIOBLASTOMA; HUMAN; HUMAN CELL; IC 50; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC AGENTS; CELL ADHESION; CELL MEMBRANE; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; FIBROBLASTS; GLIOBLASTOMA; GLYCOLIPIDS; HUMANS; MOLECULAR STRUCTURE; PROTEIN KINASE C; SIGNAL TRANSDUCTION; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP; TETRADECANOYLPHORBOL ACETATE;

EID: 79953229186     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2011.02.043     Document Type: Article

References (42)

1. M. Castagna, Y. Takai, K. Kaibuchi, K. Sano, U. Kikkawa, and Y. Nishizuka Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters J. Biol. Chem. 257 1982 7847 7851 (Pubitemid 12043279)
2. U. Kikkawa, Y. Takai, R. Miyake, and Y. Nishizuka Protein kinase C as a possible receptor protein of tumor-promoting phorbol esters J. Biol. Chem. 258 1983 11442 11445 (Pubitemid 13019291)
3. H.J. Mackay, and C.J. Twelves Targeting the protein kinase C family: are we there yet? Nat. Rev. Cancer 7 2007 554 562 (Pubitemid 46985395)
4. E.M. Griner, and M.G. Kazanietz Protein kinase C and other diacylglycerol effectors in cancer Nat. Rev. Cancer 7 2007 281 294 (Pubitemid 46480971)
5. C. Rosse, M. Linch, S. Kermorgant, A. Cameron, K. Boeckeler, and P. Parker PKC and the control of localized signal dynamics Nat. Rev. Mol. Cell. Biol. 11 2010 103 112
6. H. Cai, U. Smola, V. Wixler, I. Eisenmann-Tappe, M.T. Diaz-Meco, J. Moscat, U. Rapp, and G.M. Cooper Role of diacylglycerol-regulated protein kinase C isotypes in growth factor activation of the Raf-1 protein kinase Mol. Cell. Biol. 17 1997 732 741 (Pubitemid 27044372)
7. C.J. Marshall Cell signaling. Raf gets it together Nature 386 1996 127 128 (Pubitemid 26303963)
8. V.C. Grossoni, K.B. Falbo, M.G. Kazanietz, E.D. de Kier Joff, and A.J. Urtreger Protein kinase C delta enhances proliferation and survival of murine mammary cells Mol. Carcinog. 46 2007 381 390 (Pubitemid 46744458)
9. A. Ali, S. Ali, B. El-Rayes, P. Philip, and F. Sarkar Exploitation of protein kinase C: a useful target for cancer therapy Cancer Treat. Rev. 35 2009 1 8
10. J.B. Smith, L. Smith, and G.R. Pettit Bryostatins: potent, new mitogens that mimic phorbol ester tumor promoters Biochem. Biophys. Res. Commun. 132 1985 939 945 (Pubitemid 16201227)
11. P.A. Philip, and J.A. Zonder Pharmacology and clinical experience with bryostatin 1: a novel anticancer drug Expert Opin. Investig. Drug 8 1989 2189 2199
12. B.F. El-Rayes, S. Gadgeel, A.F. Shields, S. Manza, P. Lorusso, and P.A. Philip Phase I study of bryostatin 1 and gemcitabine Clin. Cancer Res. 12 2006 7059 7062 (Pubitemid 44974504)
13. J.K. Lin Molecular targets of curcumin Adv. Exp. Med. Biol. 595 2007 227 243
14. S. Singh, and A. Khar Biological effects of curcumin and its role in cancer chemoprevention and therapy Anticancer Agent Med. Chem. 6 2006 259 270 (Pubitemid 43796643)
15. G. Holzl, and P. Dormann Structure and function of glycoglycerolipids in plants and bacteria Prog. Lipid Res. 46 2007 225 243 (Pubitemid 47095009)
16. E. Larsen, and L.P. Christensen Common vegetables and fruits as a source of 1,2-di-O-α-linolenoyl-3-O-β-D-galactopyranosyl-sn-glycerol, a potential anti-inflammatory and antitumor agent J. Food Lipids 14 2007 272 279 (Pubitemid 47298117)
17. N. Maeda, Y. Kokai, S. Ohtani, T. Hada, H. Yoshida, and Y. Mizushina Inhibitory effects of preventive and curative orally administered spinach glycoglycerolipid fraction on the tumor growth of sarcoma and colon in mouse graft models Food Chem. 112 2009 205 210
18. Y. Matsui, T. Hada, N. Maeda, Y. Sato, Y. Yamaguchi, T. Takeuchi, M. Takemura, F. Sugawara, K. Sakaguchi, and H. Yoshida Structure and activity relationship of monogalactosyl diacylglycerols, which selectively inhibited in vitro mammalian replicative DNA polymerase activity and human cancer cell growth Cancer Lett. 283 2009 101 107
19. A. Bruno, C. Rossi, G. Marcolongo, A. Di Lena, A. Venzo, C.P. Berrie, and D. Corda Selective in vivo anti-inflammatory action of the galactolipid monogalactosyldiacylglycerol Eur. J. Pharmacol. 524 2005 159 168 (Pubitemid 41606830)
20. A. Murakami, H. Ohigashi, and K. Koshimizu Chemoprevention: insights into biological mechanisms and promising food factors Food Rev. Int. 15 1999 335 395 (Pubitemid 129492742)
21. H. Shirahashi, N. Murakami, M. Watanabe, A. Nagatsu, J. Sakakibara, H. Tokuda, H. Nishino, and A. Iwashima Glycolipids. VIII. Isolation and identification of antitumor-promoting principles from the fresh-water cyanobacterium Phormidium tenue Chem. Pharm. Bull. 41 1993 1664 1666 (Pubitemid 23326805)
22. N. Murakami, H. Imanura, J. Sakakibara, and N. Yamada Glycolipids. I. Seven new monogalactosyl diacylglycerols isolated from the axenic cyanobacterium Phormidium tenue Chem. Pharm. Bull. 38 1999 3497 3499
23. A. Murakami, Y. Nakamura, K. Koshimizu, and H. Ohigashi Glyceroglycolipids from Citrus hystrix, a traditional herb in Thailand, potently inhibit the tumor-promoting activity of 12-O-tetradecanoylphorbol 13-acetate in mouse skin J. Agric. Food Chem. 43 1995 2779 2783
24. T. Morimoto, A. Nagatsu, N. Murakami, J. Sakakibara, H. Tokuda, H. Nishino, and A. Iwashima Anti-tumour-promoting glyceroglycolipids from the green alga, Chlorella vulgaris Phytochemistry 40 1995 1433 1437
25. D. Colombo, L. Franchini, L. Toma, F. Ronchetti, R. Tanaka, J. Takayasu, H. Nishino, and H. Tokuda Cyclic and branched acyl chain galactoglycerolipids and their effect on anti-tumor-promoting activity Eur. J. Med. Chem. 41 2006 1456 1463 (and references herein reported) (Pubitemid 44880502)
26. H. Tokuda, T. Konoshima, M. Kozuka, and T. Kimura Inhibitory effects of 12-O-tetradecanoylphorbol-13-acetate and teleocidin B-induced Epstein-Barr virus by saponins and its related compounds Cancer Lett. 40 1988 309 317
27. C.B. Weldon, A. McKee, W.B.M. Collins-Buro, L.I. Melnik, A.B. Scandurro, J.A. McLachlan, M.E. Burow, and B.S. Beckman PKC-mediated survival signaling in breast carcinoma cells a role for MEK1-AP1 signaling Int. J. Oncol. 26 2005 763 768
28. H. Guo, F. Gu, W. Li, B. Zhang, R. Niu, L. Fu, N. Zhang, and Y. Ma Reduction of protein kinase C zeta inhibits migration and invasion of human glioblastoma cells J. Neurochem. 109 2009 203 213
29. M.H. Park, B.H. Ahn, Y.K. Hong, and S. do Min Overexpression of phospholipase D enhances matrix metalloproteinase-2 expression and glioma cell invasion via protein kinase C and protein kinase A/NF-kappaB/Sp1-mediated signaling pathways Carcinogenesis 30 2009 356 365
30. R.M. Baldwin, D.A. Parolin, and I.A. Lorimer Regulation of glioblastoma cell invasion by PKC iota and RhoB Oncogene 27 2008 3587 3595 (Pubitemid 351793806)
31. D. Colombo, F. Ronchetti, A. Scala, and L. Toma Bioactive glycoglycerolipid analogues: an expeditious enzymatic approach to mono- and diesters of 2-O-β-D-galactosylglycerol Tetrahedron: Asymmetry 9 1998 2113 2119 (Pubitemid 28326443)
32. P.M. Blumberg In vitro studies on the mode of action of the phorbol esters, potent tumor promoters: part 1 Crit. Rev. Toxicol. 8 1988 153 197
33. K. Danker, W. Reutter, and G. Semini Glycosidated phospholipids: uncoupling of signaling pathways at the plasma membrane Br. J. Pharmacol. 160 2010 36 47
34. P.J. Parker, L. Coessens, N. Totty, L. Rhee, S. Young, E. Chen, S. Stabel, M.D. Waterfield, and A. Ullrich The complete primary structure of protein kinase C, the major phorbol ester receptor Science 233 1986 853 859 (Pubitemid 16011893)
35. M.G. Kazanietz Novel "nonkinase" phorbol ester receptors: the C1 domain connection Mol. Pharmacol. 61 2002 759 767 (Pubitemid 34273155)
36. D. Ron, and M.G. Kazanietz New insight into the regulation of protein kinase C and novel phorbol ester receptors FASEB J. 13 1999 1658 1676 (Pubitemid 29473329)
37. R.V. Stahelin, and W. Cho Roles of calcium ions in the membrane binding of C2 domains Biochem. J. 359 2001 679 685 (Pubitemid 33063393)
38. 2+-binding domain J. Biol. Chem. 273 1998 15879 15882 (Pubitemid 28311347)
39. K. Sugita, C.F. Neville, M. Sodeoka, H. Sasai, and M. Shibasaki Stereocontrolled syntheses of phorbol analogs and evaluation of their binding affinity to PKC Tetrahedron Lett. 36 1995 1067 1070
40. G. Boijeaf Gennas, V. Talman, O. Aitio, E. Ekokoski, M. Finel, R. Tuominem, and J. Yli-Kauhaluoma Design, Synthesis, and biological activity of isophthalic acid derivatives targeted to the C1 domain of protein kinase C J. Med. Chem. 52 2009 3969 3981
41. G. Zhang, M.G. Kazanietz, P.M. Blumberg, and J.H. Hurley Crystal structure of the cys2 activator-binding domain of protein kinase c delta in complex with phorbol ester Cell 81 1995 917 924
42. N.E. Lewin, D.K. Bhattacharyya, P.M. Blumberg, and V.E. Marquez Conformationally constrained analogues of diacylglycerol (DAG). How much structural complexity is necessary for recognition and high binding affinity to protein kinase C? J. Med. Chem. 43 2000 921 944 (Pubitemid 30152299)